Saturday, Nov 23rd
Last update08:46:49 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
President-elect Donald Trump's choice to run the sprawling government agency that administers Medicare, Medicaid, and the... |
 Among the cast of characters poised to join the Trump administration, no one is as exasperating,... | ||
|
 Though seasonal illnesses like the flu are just starting to gain some traction, there’s one... |
